UNH
Unitedhealth Group Inc
$429.09
+4.47 (+1.05%)
At close · Jul 13
Market Cap
$389.68B
Shares
908,144,404
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$447.57B
+11.8%
FY2025
Net Income
$12.06B
-16.3%
FY2025
Gross Margin
88.68%
+0.4pp
FY2025
Operating Margin
4.24%
-3.8pp
FY2025
Diluted EPS
$13.23
-14.7%
FY2025
Operating Cash Flow
$19.7B
-18.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $449.71B | $447.57B | $400.28B | $371.62B | $324.16B | $287.6B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | $122.49B | $110.62B | $101.86B | $94.16B | $87.14B | $81.19B | $75.43B | |
| $353.26B | $352.23B | $308.81B | $290.83B | $257.16B | $226.23B | $201.48B | $189.7B | $178.09B | $158.45B | $144.12B | $127.16B | $115.3B | $109.56B | $99.73B | $91.98B | $85.41B | $79.32B | $73.61B | $68.78B | |
| $51.09B | $50.66B | $46.69B | $38.77B | $33.7B | $31.03B | $30.75B | $28.12B | $27B | $24.11B | $24.42B | $16.21B | $3.83B | $2.89B | $2.52B | $2.39B | $2.12B | $1.77B | $1.48B | $768M | |
| $398.63B | $396.91B | $353.58B | $332.85B | $290.46B | $256.56B | $226.4B | $214.04B | $199.25B | $177.05B | $160.42B | $140.9B | $126.65B | $119.6B | $108.1B | $99.48B | $92.04B | $85.37B | $79.71B | $74.66B | |
| — | 88.68% | 88.33% | 89.57% | 89.6% | 89.21% | 88.04% | 88.39% | 88.07% | 88.01% | 86.79% | 89.68% | 97.07% | 97.64% | 97.72% | 97.66% | 97.75% | 97.97% | 98.18% | 98.98% | |
| $61.39B | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.7B | $35.19B | $34.07B | $29.56B | $28.4B | $24.31B | $21.26B | $18.94B | $17.31B | $15.56B | $14.27B | $12.73B | $13.1B | $10.58B | |
| — | $1.7B | $1.7B | $1.6B | $1.3B | $1.2B | $1.1B | $1B | $898M | $896M | $882M | $650M | $524M | $519M | $448M | $361M | $317M | — | — | — | |
| $4.33B | $4.36B | $4.1B | $3.97B | $3.4B | $3.1B | $2.89B | $2.72B | $2.43B | $2.25B | $2.06B | $1.69B | $1.48B | $1.38B | $1.31B | $1.12B | $1.06B | $991M | $981M | $796M | |
| $430.88B | $428.6B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.9B | $185.95B | $171.91B | $146.09B | $120.2B | $112.87B | $101.36B | $93.4B | $86.29B | $80.78B | $75.92B | $67.58B | |
| $18.84B | $18.96B | $32.29B | $32.36B | $28.44B | $23.97B | $22.41B | $19.69B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B | $9.62B | $9.25B | $8.46B | $7.86B | $6.36B | $5.26B | $7.85B | |
| — | 4.24% | 8.07% | 8.71% | 8.77% | 8.33% | 8.71% | 8.13% | 7.67% | 7.56% | 7% | 7.01% | 7.87% | 7.86% | 8.37% | 8.31% | 8.35% | 7.3% | 6.48% | 10.41% | |
| $23.16B | $23.33B | $36.39B | $36.33B | $31.84B | $27.07B | $25.3B | $22.41B | $19.77B | $17.45B | $14.99B | $12.71B | $11.75B | $11B | $10.56B | $9.59B | $8.93B | $7.35B | $6.24B | $8.65B | |
| $3.96B | $4B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.7B | $1.4B | $1.19B | $1.07B | $790M | $618M | $708M | $632M | $505M | $481M | $551M | $639M | $544M | |
| $14.55B | $14.7B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B | $14.02B | $11.86B | $10.23B | $9.66B | $8.92B | $8.62B | $7.96B | $7.38B | $5.81B | $4.62B | $7.31B | |
| $1.74B | $1.89B | $4.83B | $5.97B | $5.7B | $4.58B | $4.97B | $3.74B | $3.56B | $3.2B | $4.79B | $4.36B | $4.04B | $3.24B | $3.1B | $2.82B | $2.75B | $1.99B | $1.65B | $2.65B | |
| $12.04B | $12.06B | $14.41B | $22.38B | $20.12B | $17.29B | $15.4B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | $5.63B | $5.53B | $5.14B | $4.63B | $3.82B | $2.98B | $4.65B | |
| — | 2.69% | 3.6% | 6.02% | 6.21% | 6.01% | 5.99% | 5.71% | 5.3% | 5.25% | 3.8% | 3.7% | 4.31% | 4.59% | 5% | 5.05% | 4.92% | 4.39% | 3.67% | 6.17% | |
| $770M | $751M | $837M | $763M | $519M | $447M | $366M | $400M | $396M | $265M | $56M | $55M | $0 | $48M | $0 | $0 | — | — | — | — | |
| $12.39B | $13.38B | $18.05B | $23.75B | $17.11B | $15.72B | $15.17B | $14.42B | $10.47B | $10.57B | $7.67B | $3.87B | $5.14B | $4.28B | $5.5B | $5.35B | $4.63B | $4.13B | $2.83B | $4.74B | |
| USD/shares | — | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 | $10.95 | $7.37 | $6.10 | $5.78 | $5.59 | $5.38 | $4.81 | $4.14 | $3.27 | $2.45 | $3.55 |
| USD/shares | — | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 | $5.50 | $5.28 | $4.73 | $4.10 | $3.24 | $2.40 | $3.42 |
| shares | — | 908M | 921M | 928M | 937M | 943M | 949M | 951M | 963M | 964M | 952M | 953M | 972M | 1.01B | 1.03B | 1.07B | 1.12B | 1.17B | 1.21B | 1.31B |
| shares | — | 911M | 929M | 938M | 950M | 956M | 961M | 966M | 983M | 985M | 968M | 967M | 986M | 1.02B | 1.05B | 1.09B | 1.13B | 1.18B | 1.24B | 1.36B |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $79.63B in buybacks, $56.59B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Healthcare Plans median 0.57×
EV/EBIT
—
Healthcare Plans median 18.67×
P/E (TTM)
32.31×
Healthcare Plans median 42.03×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Unitedhealthcare | $344,903,000,000 | $298,208,000,000 | $281,360,000,000 | $249,741,000,000 | $222,899,000,000 | $200,875,000,000 | $193,842,000,000 | $183,476,000,000 |
| Total Optum | $270,620,000,000 | $252,957,000,000 | $226,635,000,000 | $182,768,000,000 | $155,565,000,000 | $136,308,000,000 | $112,950,000,000 | $101,280,000,000 |
| Optumrx | $154,726,000,000 | $133,231,000,000 | $116,087,000,000 | $99,773,000,000 | $91,314,000,000 | $87,498,000,000 | $74,288,000,000 | $69,536,000,000 |
| Optumhealth | $101,957,000,000 | $105,358,000,000 | $95,319,000,000 | $71,174,000,000 | $54,065,000,000 | $39,808,000,000 | $30,317,000,000 | $24,145,000,000 |
| Optuminsight | $19,417,000,000 | $18,757,000,000 | $18,932,000,000 | $14,581,000,000 | $12,199,000,000 | $10,802,000,000 | $10,006,000,000 | $9,008,000,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Product | $53,380,000,000 | $50,226,000,000 | $42,583,000,000 | $37,424,000,000 | $34,437,000,000 | $34,145,000,000 | $31,597,000,000 |
| Service | $38,038,000,000 | $36,040,000,000 | $34,123,000,000 | $27,551,000,000 | $24,603,000,000 | $20,016,000,000 | $18,973,000,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Optum | $9,539,000,000 | $16,703,000,000 | $15,943,000,000 | $14,056,000,000 | $11,995,000,000 | $10,046,000,000 | $9,359,000,000 | $8,231,000,000 |
| Unitedhealthcare | $9,425,000,000 | $15,584,000,000 | $16,415,000,000 | $14,379,000,000 | $11,975,000,000 | $12,359,000,000 | $10,326,000,000 | $9,113,000,000 |
| Optumrx | $7,193,000,000 | $5,836,000,000 | $5,115,000,000 | $4,436,000,000 | $4,135,000,000 | $3,887,000,000 | $3,902,000,000 | $3,558,000,000 |
| Optuminsight | $2,624,000,000 | $3,097,000,000 | $4,268,000,000 | $3,588,000,000 | $3,398,000,000 | $2,725,000,000 | $2,494,000,000 | $2,243,000,000 |
| Optumhealth | -$278,000,000 | $7,770,000,000 | $6,560,000,000 | $6,032,000,000 | $4,462,000,000 | $3,434,000,000 | $2,963,000,000 | $2,430,000,000 |
Operating Margin by Segment (%)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Unitedhealthcare | 2.7% | 5.2% | 5.8% | 5.8% | 5.4% | 6.2% | 5.3% | 5% |
| Total Optum | 3.5% | 6.6% | 7% | 7.7% | 7.7% | 7.4% | 8.3% | 8.1% |
| Optumrx | 4.6% | 4.4% | 4.4% | 4.4% | 4.5% | 4.4% | 5.3% | 5.1% |
| Optumhealth | -0.3% | 7.4% | 6.9% | 8.5% | 8.3% | 8.6% | 9.8% | 10.1% |
| Optuminsight | 13.5% | 16.5% | 22.5% | 24.6% | 27.9% | 25.2% | 24.9% | 24.9% |